BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bellissimo F, Pinzone MR, Cacopardo B, Nunnari G. Diagnostic and therapeutic management of hepatocellular carcinoma. World J Gastroenterol 2015; 21(42): 12003-12021 [PMID: 26576088 DOI: 10.3748/wjg.v21.i42.12003] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Abou-Salim MA, Shaaban MA, Abd El Hameid MK, Elshaier YAMM, Halaweish F. Design, synthesis and biological study of hybrid drug candidates of nitric oxide releasing cucurbitacin-inspired estrone analogs for treatment of hepatocellular carcinoma. Bioorg Chem 2019;85:515-33. [PMID: 30807895 DOI: 10.1016/j.bioorg.2019.01.068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
2 Asemota J, Saleh M, Igbinovia O, Burns D. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma. Cureus 2020;12:e9191. [PMID: 32818122 DOI: 10.7759/cureus.9191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Jiang B, Zhang R, Zhang J, Hou Y, Chen X, Zhou M, Tian X, Hao C, Fan K, Yan X. GRP78-targeted ferritin nanocaged ultra-high dose of doxorubicin for hepatocellular carcinoma therapy. Theranostics 2019;9:2167-82. [PMID: 31149036 DOI: 10.7150/thno.30867] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 15.7] [Reference Citation Analysis]
4 Vishnevsky VA, Ayvazyan KA, Ikramov RZ, Ionkin DA, Zhavoronkova OI, Stepanova YA, Varava AB, Kovalenko YA, Zharikov YO, Goncharov AB, Olifir AA, Pakhomova AY, Bugaev SA, Zhao AV. Modern principles of hepatocellular carcinoma treatment. Ann hir gepatol 2020;25:15-26. [DOI: 10.16931/1995-5464.2020215-26] [Reference Citation Analysis]
5 Zhang GX, Liu YL, Yang M, Huang WS, Xu JH. An aptamer-based, fluorescent and radionuclide dual-modality probe. Biochimie 2020;171-172:55-62. [PMID: 32081705 DOI: 10.1016/j.biochi.2020.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen D, Zou J, Zhao Z, Tang X, Deng Z, Jia J, Liu S. TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network. Cell Death Dis 2018;9:1110. [PMID: 30382079 DOI: 10.1038/s41419-018-1150-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
7 Schellhaas B, Waldner M, Görtz R, Vitali F, Kielisch C, Pfeifer L, Strobel D, Janka R, Neurath M, Wildner D. Diagnostic accuracy and interobserver variability of Dynamic Vascular Pattern (DVP) in primary liver malignancies – A simple semiquantitative tool for the analysis of contrast enhancement patterns. CH 2017;66:317-31. [DOI: 10.3233/ch-16238] [Cited by in Crossref: 11] [Article Influence: 2.2] [Reference Citation Analysis]
8 Bao M, Zhu Q, Aji T, Wei S, Tuergan T, Ha X, Tulahong A, Hu X, Hu Y. Development of Models to Predict Postoperative Complications for Hepatitis B Virus-Related Hepatocellular Carcinoma. Front Oncol 2021;11:717826. [PMID: 34676160 DOI: 10.3389/fonc.2021.717826] [Reference Citation Analysis]
9 Armbruster M, Guba M, Andrassy J, Rentsch M, Schwarze V, Rübenthaler J, Knösel T, Ricke J, Kramer H. Measuring HCC Tumor Size in MRI-The Sequence Matters! Diagnostics (Basel) 2021;11:2002. [PMID: 34829348 DOI: 10.3390/diagnostics11112002] [Reference Citation Analysis]
10 Gougelet A, Colnot S. Hepatocellular carcinoma diagnosis: Circulating microRNAs emerge as robust biomarkers. Clin Res Hepatol Gastroenterol. 2016;40:367-369. [PMID: 26823043 DOI: 10.1016/j.clinre.2015.12.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
11 Ceccarelli M, Rullo EV, Condorelli F, Vitale F, Marco VD, Nunnari G, Pellicanò GF. Unusual Signs and Symptoms in HIV-Positive Patients Coinfected with Leishmania spp: The Importance of Neglected Tropical Disease in Differential Diagnosis. Open Access Maced J Med Sci 2018;6:843-7. [PMID: 29875857 DOI: 10.3889/oamjms.2018.186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
12 De Matteis S, Granato AM, Napolitano R, Molinari C, Valgiusti M, Santini D, Foschi FG, Ercolani G, Vespasiani Gentilucci U, Faloppi L. Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma. Dig Dis Sci. 2017;62:1872-1880. [PMID: 28527050 DOI: 10.1007/s10620-017-4615-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
13 Guo X, Guo S, Pan L, Ruan L, Gu Y, Lai J. Anti-microRNA-21/221 and microRNA-199a transfected by ultrasound microbubbles induces the apoptosis of human hepatoma HepG2 cells. Oncol Lett 2017;13:3669-75. [PMID: 28529584 DOI: 10.3892/ol.2017.5910] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
14 Qian J, Oppermann E, Tran A, Imlau U, Qian K, Vogl TJ. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model. World J Gastroenterol 2016; 22(21): 5042-5049 [PMID: 27275096 DOI: 10.3748/wjg.v22.i21.5042] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hajighasemlou S, Pakzad S, Ai J, Muhammadnejad S, Mirmoghtadaei M, Hosseinzadeh F, Gharibzadeh S, Kamali A, Ahmadi A, Verdi J. Characterization and Validation of Hepatocellular Carcinoma (HCC) Xenograft tumor as a Suitable Liver Cancer Model for Preclinical Mesenchymal Stem Cell Studies. Asian Pac J Cancer Prev 2018;19:1627-31. [PMID: 29936790 DOI: 10.22034/APJCP.2018.19.6.1627] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
16 Xu Y, Guo Q, Wei L. The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:5096. [PMID: 34680245 DOI: 10.3390/cancers13205096] [Reference Citation Analysis]
17 Lyu P, Zhai Z, Hao Z, Zhang H, He J. CircWHSC1 serves as an oncogene to promote hepatocellular carcinoma progression. Eur J Clin Invest 2021;51:e13487. [PMID: 33410156 DOI: 10.1111/eci.13487] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Beard RE, Wang Y, Khan S, Marsh JW, Tsung A, Geller DA. Laparoscopic liver resection for hepatocellular carcinoma in early and advanced cirrhosis. HPB (Oxford). 2018;20:521-529. [PMID: 29317157 DOI: 10.1016/j.hpb.2017.11.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
19 Han K, Li C, Zhang X, Shang L. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways. Biosci Rep 2019;39:BSR20181457. [PMID: 30996112 DOI: 10.1042/BSR20181457] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
20 Zhang Y, Zhang X, Zhang J, Sun B, Zheng L, Li J, Liu S, Sui G, Yin Z. Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay. Cancer Biol Ther 2016;17:1177-87. [PMID: 27662377 DOI: 10.1080/15384047.2016.1235665] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
21 Guo W, Li H, Liu H, Ma X, Yang S, Wang Z. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway. Oncol Rep 2019;42:1075-89. [PMID: 31322256 DOI: 10.3892/or.2019.7221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
22 Kumar Y, Phaniendra A, Periyasamy L. Bixin Triggers Apoptosis of Human Hep3B Hepatocellular Carcinoma Cells: An Insight to Molecular and IN SILICO Approach. Nutr Cancer 2018;70:971-83. [PMID: 30204479 DOI: 10.1080/01635581.2018.1490445] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Abdelmonsif DA, Sultan AS, El-hadidy WF, Abdallah DM. Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients. Mol Diagn Ther 2018;22:115-27. [DOI: 10.1007/s40291-017-0307-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
24 Hang X, Wu Z, Chu K, Yu G, Peng H, Xin H, Miao X, Wang J, Xu W. Low expression of DCXR protein indicates a poor prognosis for hepatocellular carcinoma patients. Tumor Biol 2016;37:15079-85. [DOI: 10.1007/s13277-016-5302-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
25 Han C, Gao L, Bai H, Dou X. Identification of a role for serum aldo-keto reductase family 1 member B10 in early detection of hepatocellular carcinoma. Oncol Lett 2018;16:7123-30. [PMID: 30546447 DOI: 10.3892/ol.2018.9547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
26 Zhao J, Xu T, Wang F, Cai W, Chen L. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73. Biomed Pharmacother 2017;90:744-51. [PMID: 28419971 DOI: 10.1016/j.biopha.2017.04.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
27 Han C, Gao L, Zhao L, Sheng Q, Zhang C, An Z, Xia T, Ding Y, Wang J, Bai H, Dou X. Immunohistochemistry Detects Increased Expression of Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) in Early-Stage Hepatocellular Carcinoma. Med Sci Monit. 2018;24:7414-7423. [PMID: 30328412 DOI: 10.12659/msm.910738] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
28 Sun X, Qian Y, Wang X, Cao R, Zhang J, Chen W, Fang M. LncRNA TRG-AS1 stimulates hepatocellular carcinoma progression by sponging miR-4500 to modulate BACH1. Cancer Cell Int 2020;20:367. [PMID: 32774161 DOI: 10.1186/s12935-020-01440-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
29 Kong W, Li X, Xu H, Gao Y. Development and validation of a m6A-related gene signature for predicting the prognosis of hepatocellular carcinoma. Biomark Med 2020;14:1217-28. [PMID: 33021385 DOI: 10.2217/bmm-2020-0178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Sung CT, Shetty A, Menias CO, Houshyar R, Chatterjee S, Lee TK, Tung P, Helmy M, Lall C. Collision and composite tumors; radiologic and pathologic correlation. Abdom Radiol (NY) 2017;42:2909-26. [PMID: 28623377 DOI: 10.1007/s00261-017-1200-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
31 Ceccarelli M, Rullo EV, Facciolà A, Madeddu G, Cacopardo B, Taibi R, D'Aleo F, Pinzone MR, Picerno I, di Rosa M, Visalli G, Condorelli F, Nunnari G, Pellicanò GF. Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review. Oncotarget 2018;9:17171-80. [PMID: 29682214 DOI: 10.18632/oncotarget.24660] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
32 Li H, Wang Y, Ma S, Zhang C, Liu H, Sun D. Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury. Sci Rep 2021;11:11642. [PMID: 34079030 DOI: 10.1038/s41598-021-91164-9] [Reference Citation Analysis]
33 Zhang Y, Zhao J, Cai J, Ye JC, Xiao YT, Mei Y, Zeng MS, Xie CM, Jiang Y, Feng GK. Integrin α6-Targeted Magnetic Resonance Imaging of Hepatocellular Carcinoma in Mice. Mol Imaging Biol 2020;22:864-72. [PMID: 31792839 DOI: 10.1007/s11307-019-01437-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Berardi G, Morise Z, Sposito C, Igarashi K, Panetta V, Simonelli I, Kim S, Goh BK, Kubo S, Tanaka S, Takeda Y, Ettorre GM, Wilson GC, Cimino M, Chan C, Torzilli G, Cheung TT, Kaneko H, Mazzaferro V, Geller DA, Han H, Kanazawa A, Wakabayashi G, Troisi RI. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis. Journal of Hepatology 2020;72:75-84. [DOI: 10.1016/j.jhep.2019.08.032] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
35 Ren YJ, Huang T, Yu HL, Zhang L, He QJ, Xiong ZF, Peng H. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein. J Huazhong Univ Sci Technolog Med Sci 2016;36:846-51. [PMID: 27924522 DOI: 10.1007/s11596-016-1673-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
36 Hernandez R, Sun H, England CG, Valdovinos HF, Ehlerding EB, Barnhart TE, Yang Y, Cai W. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody. Theranostics 2016;6:1918-33. [PMID: 27570560 DOI: 10.7150/thno.15568] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
37 Hai S, Hatano E, Okada T, Uyama N, Suzumura K, Fujimoto J. Is Noncurative Hepatic Resection Justified for Advanced Hepatocellular Carcinoma?. The American Surgeon 2018;84:1938-44. [DOI: 10.1177/000313481808401241] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
38 Chen Z, Yu W, Zhou Q, Zhang J, Jiang H, Hao D, Wang J, Zhou Z, He C, Xiao Z. A Novel lncRNA IHS Promotes Tumor Proliferation and Metastasis in HCC by Regulating the ERK- and AKT/GSK-3β-Signaling Pathways. Mol Ther Nucleic Acids 2019;16:707-20. [PMID: 31128422 DOI: 10.1016/j.omtn.2019.04.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
39 Chen Y, Zhang J, Liu J, Wang J, Shi C, Lu L, Cheng X, Niu G, Zhang S, Cui D. The Expression and Clinical Significance of PCNAP1 in Hepatocellular Carcinoma Patients. Journal of Immunology Research 2022;2022:1-7. [DOI: 10.1155/2022/1817694] [Reference Citation Analysis]
40 Zong J, Fan Z, Zhang Y. Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma. J Hepatocell Carcinoma 2020;7:413-22. [PMID: 33376710 DOI: 10.2147/JHC.S272762] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Chen X, Zhu X, Wei Z, Lv Q. Integrated mRNA‐Seq and miRNA‐Seq analysis of PLCγ2‐overexpressing hepatocarcinoma cells and identification of the associated miRNA‐mRNA network. J Cell Biochem 2019;120:19878-90. [DOI: 10.1002/jcb.29294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
42 Li Y, Lin Q, Chang S, Zhang R, Wang J. Vitamin D3 mediates miR-15a-5p inhibition of liver cancer cell proliferation via targeting E2F3. Oncol Lett 2020;20:292-8. [PMID: 32565955 DOI: 10.3892/ol.2020.11572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Elshaier YAMM, Shaaban MA, Abd El Hamid MK, Abdelrahman MH, Abou-Salim MA, Elgazwi SM, Halaweish F. Design and synthesis of pyrazolo[3,4-d]pyrimidines: Nitric oxide releasing compounds targeting hepatocellular carcinoma. Bioorg Med Chem 2017;25:2956-70. [PMID: 28487127 DOI: 10.1016/j.bmc.2017.03.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
44 Getaneh F, Atnafu A. Patterns of Hepatocellular Carcinoma on Computed Tomography at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. Ethiop J Health Sci 2020;30:209-14. [PMID: 32165810 DOI: 10.4314/ejhs.v30i2.8] [Reference Citation Analysis]
45 Jiang C, Li F, Yang M, Duan J, Lai J, Sun S, Fan S. LINC00238 inhibits hepatic carcinoma progression by activating TMEM106C‑mediated apoptosis pathway. Mol Med Rep 2021;24:757. [PMID: 34476506 DOI: 10.3892/mmr.2021.12397] [Reference Citation Analysis]
46 Xue Y, Jia X, Li L, Dong X, Ling J, Yuan J, Li Q. DDX5 promotes hepatocellular carcinoma tumorigenesis via Akt signaling pathway. Biochem Biophys Res Commun 2018;503:2885-91. [PMID: 30119889 DOI: 10.1016/j.bbrc.2018.08.063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
47 Long XR, Zhang YJ, Zhang MY, Chen K, Zheng XFS, Wang HY. Identification of an 88-microRNA signature in whole blood for diagnosis of hepatocellular carcinoma and other chronic liver diseases. Aging (Albany NY). 2017;9:1565-1584. [PMID: 28657540 DOI: 10.18632/aging.101253] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]